Resistencia del factor V a la proteína C activada
DOI:
https://doi.org/10.51481/amc.v41i2.510Palabras clave:
Trombosis, trombofilia, estado hipercoagulable, resistencia delfactor V a la proteína C activada.Resumen
Se presenta el caso de un joven de 15 años, con un cuadro de trombosis venosa profunda extensa, luego de un trauma leve. Al paciente se le encontró resistencia del factor V a la proteína C activada y los estudios familiares detectaron varios parientes con la misma deficiencia, dos de ellos con historia de tromboflebitis asociada a la ingestión de anticonceptivos orales.
Descargas
Citas
Bertina RM, Koeleman BPC, KosterT, Rosendaal R, Dirven RS, De Ronde H, Van der Velden PA, Reitsma PH. Mutation in Blood Coagulation Factor V Associated with Resistance to Activated Protein C Nature. 1994, 69:64-67.
Dahlbäck B. Inherited Thrombophilia: Resistance to Activated Protein C as a Pathogenic Factor for Venous Thromboembolism. Blood, 1995, 85:607-614.
Koeleman BPC. Reitsma P, HB Allaart CF and Bertina RM. Activated Protein C Resistance as an Addiotional Risk Factor for Thrombosis in Protein C Deficient Families. Blood. 1994, 84:1031-1035.
De Ronde H and Bertina RM. Laboratory Diagnosis of APCResistance: A Critical Evaluation of Test and The Developmen of Diagnostic Criteria. Thromb Haemost. 1994, 72:880-886.
Dahlbäck B, Carlsson M and Svensson P J. Familial Thrombophilia Due to a Previously Unrecognized Mechanism Charaterized by Poor Anticoagulant Response to Acti vated Protein C; prediction of a Cofactor to Activated Protein C. Proc Natl Acad Sciences USA, 1993, 90:1004-1008.
Sinfontes MT, Nuss R, Jacobson LL. Griffin JH, Manco-Johnson M. Thrombosis in Otherwise Well Children with the Factor V Leiden Mutation. J Pediatr, 1996, 128:324-328.
Grandille JS, Greengard M, Alhenc Gelas M, Juhan-Vague J, Abgrall JF, Jude 8, Grifin JH, Aicach M and the French Network on the Behalf of INSERM. Incidence of Activated Protein C Resistance caused by the Arg 506 Gln Mutation in Factor V in 113 Unrelated Symptomatic Protein C Deficient Patients. Blood, 1995, 86:219-224.
Heeb MJ, Kojima V, Greemgard JS and Griffin JH. Activated
Protein C Resistance: Molecular Mechanims Based on studies Using Purified Gin-Factor V. Blood, 1995, 85:3405-3411.
Rosendaal FR, KosterT, Vandenbroucke JP and Reitsma PH High Risk of Thrombosis in Patients Homozygous for Factor V Leiden (Activated Protein C Resistance). Blood, 1995, 85:1504-1508.
Koster T, Rosendaal FR, De Ronde H, VBriet E, Vanderbroucke JP and Bertina RM. Venous Thrombosis due to Poor Anticoagulant Reponse to APC: Leiden Thrombophilia Study Lancet. 1993, 342:1053-1056.
l l . Svensson PJ, and Dahlbäck B. Resistance to Activated Protein C as Basis for venous Thrombosis. N Engl J Med. 1994, 330:517520.
Herrmann FH, Koesling M, Schroder M, Altman, R Jiménez Bonilla, R Lopaciuk S, Pérez Requejo Jl, Singh JR. Prevalence of Factor V Leiden Mutation in Various Populations. Genet Epidemiol. 1997,
Zoller B , Bersdatter A, Garcia de Frutos P, Dahlbäck B. Resistance to Activated Protein C as an Additional Genetic Risk Factor in Hereditary Deficiency of Protein S. Blood. 1995, 85:3518-3523.
Oliviero O, Frisso S, Manzato F, Guella A, Bernardi F, Lunghi B, Girelli D, Azzini M, Brocco G, Russo C and Corrocher R. Resistance to Activated Protein C in Healthy women Taking Oral Contraceptives. Br J Haematol. 1995, 95:465-470.
Bucalossi A, Marotta G, Bigazzi C, Galieni P and Dispensa E. Reduction of Antithrombin Ill Protein C and Protein S Levels and Activated Protein C Resistance in Polycythemia Vera and Essential Thrombocythemia atients with Thrombosis. Am J Hematol. 1996, 52:14-20.
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2009 Acta Médica Costarricense
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
Los autores que publican en la revista Acta Médica Costarricense pueden distribuir, copiar, remezclar, retocar, leer, descargar, imprimir, buscar y crear a partir de su obra de modo no comercial, indicando los créditos a la revista y sus autores y compartir su obra en las mismas condiciones. Para ello se aplica la licencia Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional(CC BY-NC-SA 4.0)
